Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
China · Delayed Price · Currency is CNY 39.17
+1.29 (3.41%)
Jun 11, 2026, 2:15 PM CST
SHA:603139 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -295.33 | -333.45 | -89.63 | -26.16 | -63.06 | 36.48 |
Depreciation & Amortization | 65.86 | 65.86 | 59.89 | 37.71 | 25.34 | 16.37 |
Other Amortization | 1.44 | 1.44 | 1.09 | 1.01 | 6.46 | 0.43 |
Loss (Gain) From Sale of Assets | 0.31 | 0.31 | -0.66 | -0.1 | 0.02 | - |
Asset Writedown & Restructuring Costs | 165.34 | 165.34 | 1.2 | 16.9 | 11.53 | 0.01 |
Loss (Gain) From Sale of Investments | 8.33 | 8.33 | 31.15 | 28.74 | 54.83 | -23.44 |
Provision & Write-off of Bad Debts | 16.44 | 16.44 | 5.92 | 0.83 | 8.78 | 1.71 |
Other Operating Activities | 76.62 | 65.64 | 29.37 | 5.73 | 4.66 | 12.47 |
Change in Accounts Receivable | -24.05 | -24.05 | 24.45 | -82.39 | -26.84 | 1.25 |
Change in Inventory | 8.29 | 8.29 | -9.87 | 28.45 | -7.09 | -9.22 |
Change in Accounts Payable | 19.35 | 19.35 | -1.93 | -65.29 | 44.77 | -26.99 |
Change in Other Net Operating Assets | -0.04 | -0.04 | 0.26 | -4.82 | - | - |
Operating Cash Flow | 32.38 | -16.72 | 37.29 | -72.13 | 50.43 | 7.42 |
Operating Cash Flow Growth | 165.33% | - | - | - | 579.82% | -92.08% |
Capital Expenditures | -38.71 | -15.53 | -46.66 | -72.38 | -138.13 | -290.3 |
Sale of Property, Plant & Equipment | 45.4 | 0.19 | 6.51 | 0.32 | 0.14 | 0.08 |
Cash Acquisitions | 1.46 | 1.49 | -3.01 | 25.34 | - | -8.26 |
Divestitures | 5.38 | 5.38 | - | 0.98 | - | - |
Investment in Securities | -9.97 | -9.83 | 26.02 | -0.55 | 87.42 | -97.38 |
Other Investing Activities | 7.66 | - | 0.62 | 0.33 | 7.17 | 16.89 |
Investing Cash Flow | 11.22 | -18.3 | -16.52 | -45.97 | -43.4 | -378.98 |
Short-Term Debt Issued | - | 3.9 | 3.62 | 3.13 | 11.73 | 1.93 |
Long-Term Debt Issued | - | 326.05 | 341.12 | 322.65 | 231.36 | 476.9 |
Total Debt Issued | 281.36 | 329.95 | 344.74 | 325.78 | 243.1 | 478.83 |
Short-Term Debt Repaid | - | -2.54 | -8.9 | -2.05 | -0.79 | -2.77 |
Long-Term Debt Repaid | - | -270.31 | -375.61 | -235.23 | -205.62 | -65.39 |
Total Debt Repaid | -329.98 | -272.85 | -384.52 | -237.28 | -206.41 | -68.16 |
Net Debt Issued (Repaid) | -48.62 | 57.1 | -39.78 | 88.49 | 36.68 | 410.67 |
Common Dividends Paid | -26.57 | -27.86 | -28.93 | -30.73 | -32.26 | -33.38 |
Other Financing Activities | -27.34 | -4 | 2.71 | -3.12 | 3.17 | 1.02 |
Financing Cash Flow | -102.52 | 25.24 | -65.99 | 54.65 | 7.59 | 378.31 |
Net Cash Flow | -58.92 | -9.78 | -45.22 | -63.45 | 14.63 | 6.75 |
Free Cash Flow | -6.32 | -32.25 | -9.37 | -144.52 | -87.7 | -282.88 |
Free Cash Flow Margin | -1.43% | -6.84% | -1.67% | -21.48% | -17.84% | -63.89% |
Free Cash Flow Per Share | -0.06 | -0.32 | -0.09 | -1.44 | -0.88 | -2.87 |
Cash Income Tax Paid | 30.26 | 29.13 | 42.64 | 31.71 | -12.11 | 18.01 |
Levered Free Cash Flow | 119.39 | 165.85 | -20.57 | -123.73 | -141.29 | -237.69 |
Unlevered Free Cash Flow | 140.4 | 187.31 | 1.17 | -109.07 | -133.02 | -233.74 |
Change in Working Capital | -6.63 | -6.63 | -1.04 | -136.81 | 1.87 | -36.62 |